FRANCESCO DE RUBERTIS
Co-founder and Partner, Medicxi
Francesco’s prior investments include CellZome, GenMab, GenSight Biologics, Micromet, Minerva Neurosciences, Molecular Partners, PanGenetics, Parallele Biosciences, Profibrix and Versartis.
Francesco received a BA in Genetics and Microbiology from the University of Pavia and a PhD Molecular Biology from the University of Geneva. He conducted postdoctoral research at the Whitehead Institute at MIT and is a CFA Charterholder. Francesco also serves on the strategic advisory board of the University of Geneva.
17 November 2020
BOOK YOUR PLACE NOW